FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / comprehensive-compliance-framework-report.docx
comprehensive-compliance-framework-report.docx · 1037-00003

Parties

Solstice Biomedical Devices Ltd
Solstice Biomedical Inc
Harkness LLP
Advisory LLP
Meridian Consulting Group LLC
Scope Solstice Biomedical Devices Ltd
Vantage Medical Technologies Inc
Ascendant Distribution Solutions LLC

Dates

August 12, 2024
April 8, 2024
August 15, 2024
April 5, 2024
February 9, 2024
January 22, 2024
October 1, 2024
December 31, 2025
December 31, 2023
December 12, 2023

Amounts

$26
€187
€640
€38.4
$35
$214
$500
$2,000
$4,950
$2,500

Obligations

We have identified several time-critical remediation items — particularly with respect to the sales compensation accelerator structure, promotional materials revisions, ADS Distribution Agreement amendments, state registrations, and compliance training — that must be addressed on an expedited basis to meet the launch timeline
Both registrations must be in effect before any commercial sales activity in those states
The application was submitted in June 2024 and must be confirmed and finalized before the launch date to ensure Open Payments reporting capability
Training curriculum has been developed; delivery must be completed and certifications obtained before launch
The system must be operational before the first transfer of value to a covered recipient, which will occur at or near launch
All financial arrangements between Solstice (or its distributor, ADS) and physicians, hospitals, health systems, and other healthcare professionals or entities that are in a position to order, recommend, or influence the purchase or use of the Pulsar CRM System must be carefully structured to comply with the AKS and, where possible, to satisfy one or more of the statutory safe harbors